US Patent 9034892 Forms of rifaximin and uses thereof
Patent 9034892 was granted and assigned to Salix Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9034892 Forms of rifaximin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.